These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity. Yoshioka J; Schulze PC; Cupesi M; Sylvan JD; MacGillivray C; Gannon J; Huang H; Lee RT Circulation; 2004 Jun; 109(21):2581-6. PubMed ID: 15123525 [TBL] [Abstract][Full Text] [Related]
48. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1. Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503 [TBL] [Abstract][Full Text] [Related]
49. The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling. Zhu Y; Li T; Song J; Liu C; Hu Y; Que L; Ha T; Kelley J; Chen Q; Li C; Li Y Basic Res Cardiol; 2011 Sep; 106(5):787-99. PubMed ID: 21533832 [TBL] [Abstract][Full Text] [Related]
50. Ca²⁺ signal-induced cardiomyocyte hypertrophy through activation of myocardin. Li M; Wang N; Gong HQ; Li WZ; Liao XH; Yang XL; He HP; Cao DS; Zhang TC Gene; 2015 Feb; 557(1):43-51. PubMed ID: 25485719 [TBL] [Abstract][Full Text] [Related]
51. Transient receptor potential vanilloid 2 function regulates cardiac hypertrophy via stretch-induced activation. Koch SE; Mann A; Jones S; Robbins N; Alkhattabi A; Worley MC; Gao X; Lasko-Roiniotis VM; Karani R; Fulford L; Jiang M; Nieman M; Lorenz JN; Rubinstein J J Hypertens; 2017 Mar; 35(3):602-611. PubMed ID: 28009703 [TBL] [Abstract][Full Text] [Related]
52. L-type calcium channel modulates mechanosensitivity of the cardiomyocyte cell line H9c2. Takahashi K; Hayashi S; Miyajima M; Omori M; Wang J; Kaihara K; Morimatsu M; Wang C; Chen J; Iribe G; Naruse K; Sokabe M Cell Calcium; 2019 May; 79():68-74. PubMed ID: 30836292 [TBL] [Abstract][Full Text] [Related]
53. APJ acts as a dual receptor in cardiac hypertrophy. Scimia MC; Hurtado C; Ray S; Metzler S; Wei K; Wang J; Woods CE; Purcell NH; Catalucci D; Akasaka T; Bueno OF; Vlasuk GP; Kaliman P; Bodmer R; Smith LH; Ashley E; Mercola M; Brown JH; Ruiz-Lozano P Nature; 2012 Aug; 488(7411):394-8. PubMed ID: 22810587 [TBL] [Abstract][Full Text] [Related]
54. Polycystin-1 mitigates damage and regulates CTGF expression through AKT activation during cardiac ischemia/reperfusion. Aránguiz P; Romero P; Vásquez F; Flores-Vergara R; Aravena D; Sánchez G; González M; Olmedo I; Pedrozo Z Biochim Biophys Acta Mol Basis Dis; 2021 Jan; 1867(1):165986. PubMed ID: 33065236 [TBL] [Abstract][Full Text] [Related]
55. Myoscape controls cardiac calcium cycling and contractility via regulation of L-type calcium channel surface expression. Eden M; Meder B; Völkers M; Poomvanicha M; Domes K; Branchereau M; Marck P; Will R; Bernt A; Rangrez A; Busch M; ; Hrabě de Angelis M; Heymes C; Rottbauer W; Most P; Hofmann F; Frey N Nat Commun; 2016 Apr; 7():11317. PubMed ID: 27122098 [TBL] [Abstract][Full Text] [Related]
56. Cardiomyocyte Ogt limits ventricular dysfunction in mice following pressure overload without affecting hypertrophy. Dassanayaka S; Brainard RE; Watson LJ; Long BW; Brittian KR; DeMartino AM; Aird AL; Gumpert AM; Audam TN; Kilfoil PJ; Muthusamy S; Hamid T; Prabhu SD; Jones SP Basic Res Cardiol; 2017 May; 112(3):23. PubMed ID: 28299467 [TBL] [Abstract][Full Text] [Related]
57. Lats2 is a negative regulator of myocyte size in the heart. Matsui Y; Nakano N; Shao D; Gao S; Luo W; Hong C; Zhai P; Holle E; Yu X; Yabuta N; Tao W; Wagner T; Nojima H; Sadoshima J Circ Res; 2008 Nov; 103(11):1309-18. PubMed ID: 18927464 [TBL] [Abstract][Full Text] [Related]
58. Polycystin-2-dependent control of cardiomyocyte autophagy. Criollo A; Altamirano F; Pedrozo Z; Schiattarella GG; Li DL; Rivera-Mejías P; Sotomayor-Flores C; Parra V; Villalobos E; Battiprolu PK; Jiang N; May HI; Morselli E; Somlo S; de Smedt H; Gillette TG; Lavandero S; Hill JA J Mol Cell Cardiol; 2018 May; 118():110-121. PubMed ID: 29518398 [TBL] [Abstract][Full Text] [Related]
59. [Ca2+ is involved in tumor necrosis factor-alpha induced cardiomyocyte hypertrophy through PI3-kinase pathway in rats]. Wang GJ; Yao YS; Li ZP; Wang HX Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2010 Aug; 26(3):284-8. PubMed ID: 21038670 [TBL] [Abstract][Full Text] [Related]
60. Resistance to pathologic cardiac hypertrophy and reduced expression of CaV1.2 in Trpc3-depleted mice. Han JW; Lee YH; Yoen SI; Abramowitz J; Birnbaumer L; Lee MG; Kim JY Mol Cell Biochem; 2016 Oct; 421(1-2):55-65. PubMed ID: 27522668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]